Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ferdinando Dianzani

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Phenomena

Viral Interference

Concepts & Ideas

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Riva E; Maggi F; Abbruzzese F; Bellomi F; Giannelli G; Picardi A; Scagnolari C; Folgori A; Spada E; Piccolella E; Dianzani F; Antonelli G;
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.
Carosi G; Torti C; Andreoni M; Angarano G; Antinori A; Bonora S; Borderi M; Castagna A; Castelli F; Cauda R; Chiodo F; D'arminio-Monforte A; De Luca A; Di Perri G; Dianzani F; Filice G; Galli M; Lazzarin A; Maggiolo F; Maserati R; Mazzotta F; Moroni M; Perno C F; Vullo V
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).
Dianzani F; Frascione E
Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ferdinando Dianzani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Riva E; Maggi F; Abbruzzese F; Bellomi F; Giannelli G; Picardi A; Scagnolari C; Folgori A; Spada E; Piccolella E; Dianzani F; Antonelli G;
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.
Medical microbiology and immunology 2009;198(1):13-8.
2006: Carosi G; Torti C; Andreoni M; Angarano G; Antinori A; Bonora S; Borderi M; Castagna A; Castelli F; Cauda R; Chiodo F; D'arminio-Monforte A; De Luca A; Di Perri G; Dianzani F; Filice G; Galli M; Lazzarin A; Maggiolo F; Maserati R; Mazzotta F; Moroni M; Perno C F; Vullo V
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).
The Journal of antimicrobial chemotherapy 2006;57(6):1055-64.
2003: Dianzani F; Frascione E
Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.
Scandinavian journal of infectious diseases. Supplementum 2003;106():108-9.
2003: Dianzani Ferdinando
Viral resistance to chemotherapeutic agents: an expectable unexpected phenomenon.
Scandinavian journal of infectious diseases. Supplementum 2003;106():6-7.
2001: Perno C F; Cozzi-Lepri A; Balotta C; Forbici F; Violin M; Bertoli A; Facchi G; Pezzotti P; Cadeo G; Tositti G; Pasquinucci S; Pauluzzi S; Scalzini A; Salassa B; Vincenti A; Phillips A N; Dianzani F; Appice A; Angarano G; Monno L; Ippolito G; Moroni M; d' Arminio Monforte A;
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy.
The Journal of infectious diseases 2001;184(8):983-91.
2000: Rezza G; Lepri A C; d'Arminio Monforte A; Pezzotti P; Castelli F; Dianzani F; Lazzarin A; De Luca A; Arlotti M; Leoncini F; Manconi P E; Rizzardini G; Minoli L; Poggio A; Ippolito G; Phillips A N; Moroni M
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group.
Journal of acquired immune deficiency syndromes (1999) 2000;25(1):56-62.
1999: Antonelli G; Dianzani F
Development of antibodies to interferon beta in patients: technical and biological aspects.
European cytokine network 1999;10(3):413-22.
1998: Arnason B G; Dianzani F
Correlation of the appearance of anti-interferon antibodies during treatment and dimunition of efficacy: summary of an International Workshop on Anti-Interferon Antibodies.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(8):639-44.
1997: Floridia M; Vella S; Seeber A C; Tomino C; Fragola V; Weimer L E; Ricciardulli D; Milazzo F; Gritti F M; Mazzotta F; Ranieri S; Chiodo F; Moroni M; Cargnel A; Bassetti D; Giannini V; Cremoni L; Concia E; Sinicco A; Carosi G; Alberici F; Dianzani F
A randomized trial (ISS 902) of didanosine versus zidovudine in previously untreated patients with mildly symptomatic human immunodeficiency virus infection.
The Journal of infectious diseases 1997;175(2):255-64.
1996: Vella S; Floridia M; Dally L G; Tomino C; Fragola V; Weimer L E; Milazzo F; Mazzotta F; Moroni M; Pastore G; Scalise G; Sinicco A; Ortona L; De Rienzo B; Dianzani F
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(5):462-9.
1996: Dianzani F; Antonelli G; Riva E; Uccini S; Visco G
Plasma HIV viremia and viral load in lymph nodes.
Nature medicine 1996;2(8):832-3.
1996: Dianzani F
The dilemma of exposing or burying a complementary medical approach.
Journal of biological regulators and homeostatic agents 1996;10(2-3):29.
1995: Caprilli R; Peña A; Dianzani F; Pallone F; Vernia P
Pathogenetic mechanisms of inflammatory bowel disease.
The Italian journal of gastroenterology 1995;27(6):313-26.
1995: Roffi L; Mels G C; Antonelli G; Bellati G; Panizzuti F; Piperno A; Pozzi M; Ravizza D; Angeli G; Dianzani F
Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management.
Hepatology (Baltimore, Md.) 1995;21(3):645-9.
1995: Del Vecchio S; Dianzani F
[The drug of first choice: interferon. Clinical pharmacological principles]
Minerva gastroenterologica e dietologica 1995;41(1):81-7.
1994: Alfinito F; Lamberti A; Capobianchi M R; Nigro M; De Rosa G; Tassone P; Turco M C; Dianzani F; Venuta S
T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(8):1294-300.
1994: Ippolito G; Del Poggio P; Arici C; Gregis G P; Antonelli G; Riva E; Dianzani F
Transmission of zidovudine-resistant HIV during a bloody fight.
JAMA : the journal of the American Medical Association 1994;272(6):433-4.
1994: Baron S; Dianzani F
The interferons: a biological system with therapeutic potential in viral infections.
Antiviral research 1994;24(2-3):97-110.
1994: Gentile M; Adrian T; Scheidler A; Ewald M; Dianzani F; Pauli G; Gelderblom H R
Determination of the size of HIV using adenovirus type 2 as an internal length marker.
Journal of virological methods 1994;48(1):43-52.
1994: Zinzani P L; Levrero M G; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro F R; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Haematologica 1994;79(1):55-60.
1993: Natoli C; Dianzani F; Mazzotta F; Balocchini E; Pierotti P; Antonelli G; Iacobelli S
90K protein: a new predictor marker of disease progression in human immunodeficiency virus infection.
Journal of acquired immune deficiency syndromes 1993;6(4):370-5.
1993: Antonelli G; Dianzani F
Antibodies to interferon alpha in patients.
Archives of virology. Supplementum 1993;8():271-7.
1991: Morra E; Alimena G; Lazzarino M; Liberati A M; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Dianzani F
Evolving modalities of treatment with interferon alfa-2b for Ph1-positive chronic myelogenous leukaemia.
European journal of cancer (Oxford, England : 1990) 1991;27 Suppl 4():S14-7.
1990: Dianzani F; Antonelli G; Capobianchi M R
Biological activity of gamma interferon.
Annali dell'Istituto superiore di sanità 1990;26(3-4):255-61.
1989: Baron S; Niesel D; Singh I P; McKerlie L; Poast J; Chopra A; Antonelli G; Dianzani F; Coppenhaver D H
Recently described innate broad spectrum virus inhibitors.
Microbial pathogenesis 1989;7(4):237-47.
1987: Dianzani F; Zampieri A
The Italian National Research Council and hospital infections.
Chemioterapia : international journal of the Mediterranean Society of Chemotherapy 1987;6(3):161-3.
1987: Ausiello C M; Spagnoli G C; Antonelli G; Malavasi F; Dianzani F; Casciani C U; Cassone A
Generation and characterization of cytotoxic activity against tumor cell lines in human peripheral blood mononuclear cells stimulated "in vitro" by a glucomannan-protein preparation of Candida albicans.
Journal of biological regulators and homeostatic agents 1987;1(2):59-68.
1987: Ausiello C; Spagnoli G C; Antonelli G; Malavasi F; Casciani C U; Dianzani F
Influence of monoclonal antibodies against HLA class I and class II antigen on interferon-gamma and -alpha induction.
Journal of interferon research 1987;7(2):133-43.
1987: Stanton G J; Weigent D A; Fleischmann W R; Dianzani F; Baron S
Interferon review.
Investigative radiology 1987;22(3):259-73.
1987: Maleci A; Antonelli G; Guidetti B; Dianzani F
Pharmacokinetics of recombinant interferon-alpha 2 following intralesional administration in malignant glioma patients.
Journal of interferon research 1987;7(1):107-9.
1987: Antonelli G; Santiano M; Romano P; Colizzi V; Dianzani F
Inhibition of contact sensitivity to oxazolone by the calmodulin inhibitor trifluoroperazine.
International journal of immunopharmacology 1987;9(2):237-41.
1987: Dianzani F; Dolei A
[The interferon system]
Annali dell'Istituto superiore di sanità 1987;23(4):765-8.
1986: Dolei A; Fattorossi A; D'Amelio R; Aiuti F; Dianzani F
Direct and cell-mediated effects of interferon-alpha and -gamma on cells chronically infected with HTLV-III.
Journal of interferon research 1986;6(5):543-9.
1986: Antonelli G; Dianzani F
Antigen presentation by specifically sensitized macrophages in interferon-gamma induction.
Journal of interferon research 1986;6(5):535-42.
1986: Piccolella E; Dolei A; Lombardi G; Vismara D; Pizzoli P; Colizzi V; Dianzani F
Regulation of immune interferon production during the response to soluble microbial antigens.
Clinical and experimental immunology 1986;65(1):190-7.
1986: Dianzani F; Dolei A; Di Marco P
A new type of human interferon produced by peripheral blood mononuclear cells treated with inhibitors of transcription.
Journal of interferon research 1986;6(1):43-50.
1986: Piccolella E; Lombardi G; Vismara D; Del Gallo F; Colizzi V; Dolei A; Dianzani F
Effects of dexamethasone on human natural killer cell cytotoxicity, interferon production, and interleukin-2 receptor expression induced by microbial antigens.
Infection and immunity 1986;51(2):712-4.
1986: Antonelli G; Dianzani F; Coppenhaver D H; Baron S; Calandra P; Folchitto G
An influenza virus inhibitor that acts late in the replication cycle.
Antimicrobial agents and chemotherapy 1986;29(1):49-51.
1986: Dianzani F; Antonelli G; Capobianchi M R
Induction of human immune interferon with ionophores.
Methods in enzymology 1986;119():69-72.
1985: Matteucci D; Paglianti M; Giangregorio A M; Capobianchi M R; Dianzani F; Bendinelli M
Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines.
Journal of virology 1985;56(2):651-4.
1985: Antonelli G; Blalock J E; Dianzani F
Generation of a soluble IFN-gamma inducer by oxidation of galactose residues on macrophages.
Cellular immunology 1985;94(2):440-6.
1985: Pandolfi F; Capobianchi M; Matricardi P; Facchini J; Bonomo G; De Rossi G; Semenzato G; Fiorilli M; Dianzani F; Aiuti F
Impaired gamma interferon production by cells from patients with lymphoproliferative disorders of mature T and NK cells.
Scandinavian journal of immunology 1985;21(4):315-20.
1985: Antonelli G; Calandra P; Facchini J; Baron S; Dianzani F
[Natural inhibitors of viral replication of low molecular weight]
Giornale italiano di chemioterapia 1985;32(1):105-8.
1985: Dianzani F; Santiano M; Ramenghi U; Capobianchi M R; Antonelli G
Membrane events leading to interferon-gamma induction by antigens.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1985;178(1):139-42.
1985: Dolei A; Fattorossi A; D'Amelio R; Aiuti F; Dianzani F
[Direct and mediated effects of the interferon system on human retroviruses]
Giornale italiano di chemioterapia 1985;32(1):131-5.
1985: Dianzani F; Dolei A
Interferon: fantasies and facts.
Developments in biological standardization 1985;60():3-13.
1983: Jordan C; Baron S; Dianzani F; Barber J; Stanton G J
Ocular herpes simplex virus infection is diminished by depletion of B lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 1983;131(3):1554-7.
1983: Sarzotti M; Landolfo S; Dianzani F
Immune (gamma) interferon production by a murine T cell lymphoma: requirements for macromolecular synthesis and lack of relationship with cell cycle.
Infection and immunity 1983;41(2):624-30.
1982: Dianzani F; Monahan T M; Santiano M
Membrane alteration responsible for the induction of gamma interferon.
Infection and immunity 1982;36(3):915-7.
1981: Dianzani F; Monahan T M; Jordan C A; Langford M P
Inhibition of RNA synthesis in human lymphoid cells induces interferon production.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1981;167(3):338-42.
1981: Dianzani F; Monahan T; Santiano M
Mechanism of induction of gamma interferon.
Texas reports on biology and medicine 1981;41():99-107.
1981: Baron S; Dianzani F; Stanton G J
General considerations of the interferon system.
Texas reports on biology and medicine 1981;41():1-12.
1981: Dianzani F; Baron S
Differentiation of types of interferon by kinetics of development of the antiviral state.
Methods in enzymology 1981;78(Pt A):409-14.
1981: Stanton G J; Langford M P; Dianzani F
Virus yield-reduction assay for interferon by titration of Sindbis virus hemagglutinin.
Methods in enzymology 1981;78(Pt A):351-7.
1981: Johnson H M; Dianzani F; Georgiades J A
Large-scale induction and production of human and mouse immune interferons.
Methods in enzymology 1981;78(Pt A):158-62.
1980: Dianzani F; Monahan T M; Georgiades J; Alperin J B
Human immune interferon: induction in lymphoid cells by a calcium ionophore.
Infection and immunity 1980;29(2):561-3.
1980: Albrecht T; Zucca M; Dianzani F
[An inhibitor of the replication of varicella-zoster virus]
Giornale italiano di chemioterapia 1980;27(2):103-6.
1980: Dianzani F; Zucca M; Scupham A; Georgiades J A
Immune and virus-induced interferons may activate cells by different derepressional mechanisms.
Nature 1980;283(5745):400-2.
1980: Baron S; Blalock J E; Dianzani F; Fleischmann W R; Georgiades J A; Johnson H M; Stanton G J
Immune interferon: some properties and functions.
Annals of the New York Academy of Sciences 1980;350():130-44.
1979: Fleischmann W R; Georgiades J A; Osborne L C; Dianzani F; Johnson H M
Induction of an inhibitor of interferon action in a mouse lymphokine preparation.
Infection and immunity 1979;26(3):949-55.
1979: Dianzani F; Monahan T M; Scupham A; Zucca M
Enzymatic induction of interferon production by galactose oxidase treatment of human lymphoid cells.
Infection and immunity 1979;26(3):879-82.
1979: Langford M P; Georgiades J A; Stanton G J; Dianzani F; Johnson H M
Large-scale production and physicochemical characterization of human immune interferon.
Infection and immunity 1979;26(1):36-41.
1979: Iannuzzi C; Barbaro S; Viano I; Zucca M; Marazzi M G; Fonzo D; Campelli A; Lenti Bologna M; Dianzani F
Immunogenicity of a killed E. coli 0111:K58 vaccine administered orally to children.
Giornale di batteriologia, virologia ed immunologia 1979;71(1-6):100-6.
1978: Dianzani F; Salter L; Fleischmann W R; Zucca M
Immune interferon activates cells more slowly than does virus-induced interferon.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1978;159(1):94-7.
1978: Dianzani F; Gullino P; Baron S
Rapid activation of the interferon system in vivo.
Infection and immunity 1978;20(1):55-7.
1978: Dianzani F; Viano I; Santiano M; Zucca M; Gullino P; Baron S
Tissue culture models of in vivo interferon production and action.
Advances in experimental medicine and biology 1978;110():119-31.
1977: Ohtsuki K; Dianzani F; Baron S
Decreased initiation factor activity in mouse L cells treated with interferon.
Nature 1977;269(5628):536-8.
1977: Dianzani F; Baron S
The continued presence of interferon is not required for activation of cells by interferon.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1977;155(4):562-6.
1977: Dianzani F; Viano I; Santiano M; Zucca M; Baron S
Effect of cell density of development of the antiviral state in interferon-producing cells: a possible model of in vivo conditions.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1977;155(3):445-8.
1977: Giovarelli M; Viano I; Zucca M; Valbonesi R; Dianzani F
Effect of anti-mu-chain-specific immunosuppression on Chikungunya virus encephalitis of mice.
Infection and immunity 1977;16(3):849-52.
1977: Baron S; Dianzani F
General considerations of the interferon system.
Texas reports on biology and medicine 1977;35():1-10.
1977: Dianzani F; Baron S
Activation by interferon of the events leading to the antiviral state.
Texas reports on biology and medicine 1977;35():297-306.
1976: Dianzani F; Levy H B; Berg S; Baron S
Kinetics of the rapid action of interferon.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1976;152(4):593-7.
1976: Barbaro S; Zucca M; Bologna L M; Viano I; Martinotti G; Fonzo D; Dianzani F
[Oral immunization of human adult volunteers using a trivalent coli-vaccine]
Giornale di batteriologia, virologia ed immunologia 1976;69(1-6):85-90.
1975: Dianzani F; Baron S
Unexpectedly rapid action of human interferon in physiological conditions.
Nature 1975;257(5528):682-4.
1975: Tolentino P; Dianzani F; Zucca M; Giacchino R
Decreased interferon response by lymphocytes from children with chronic hepatitis.
The Journal of infectious diseases 1975;132(4):459-61.
1975: Barbaro S; Viano I; Varesio L; Bologna Lenti M; Zucca M; Dianzani F
[Oral immunization of rabbits against enteropathogenic serotypes of E. coli. II. Production of circulating and fecal antibodies induced with monovalent and polyvalent vaccines]
Giornale di batteriologia, virologia ed immunologia 1975;68(7-12):305-10.
1975: Dianzani F
Viral interference and interferon.
La Ricerca in clinica e in laboratorio 1975;5(3):196-213.
1974: Dianzani F; Viano I; Zucca M
[Prospects in the use of the interferon system in the prevention and treatment of viral infections]
Giornale italiano di chemioterapia 1974;21(2):67-78.
1974: Dianzani F; Pugliese A; Baron S
Induction of interferon by nonreplicating single-stranded RNA virus.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1974;145(2):428-33.
1973: Dianzani F
[Proceedings: Current prospects in antiviral chemotherapy]
Minerva medica 1973;64(78):4100-6.
1973: Barbaro S; Varesio L; Paradisi L; Bologna M; Dianzani F
[Oral immunization of the rabbit against enteropathogenic serotypes of E. coli. Research on the production of circulating and fecal antibodies]
Giornale di batteriologia, virologia ed immunologia ed annali dell'Ospedale Maria Vittoria di Torino. Parte 1: Sezione microbiologica 1973;66(7-12):260-8.
1972: Dianzani F; Neri P; Zucca M
Effect of dibutyryl cyclic AMP on interferon production by cells treated with viral or nonviral inducers. 1.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1972;140(4):1375-8.
1972: Dianzani F; Forni G; Negro Ponzi A; Pugliese A; Cavallo G
Decreased interferon response to polyinosinic-polycytidylic acid in rabbits immunized against the inducer.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1972;139(1):93-5.
1971: Dianzani F; Baron S; Buckler C E; Levy H B
Mechanisms of DEAE-dextran enhancement of polynucleotide induction of interferon.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1971;136(4):1111-4.
1971: Dianzani F
[Recovery mechanisms in viral infections]
Giornale di batteriologia, virologia, ed immunologia ed annali dell'Ospedale Maria Vittoria di Torino 1971;64(1):12-8.
1970: Cavallo G; Forni G; Negro Ponzi A; Dianzani F
[Depression of antibody response to sheep erythrocytes in RNA immunized rabbits. Preliminary studies]
Giornale di batteriologia, virologia, ed immunologia ed annali dell'Ospedale Maria Vittoria di Torino 1970;63(7):231-4.
1970: Dianzani F; Forni G; Negro Ponzi A
[Immunization against nucleic acids and interferon production. Preliminary studies]
Giornale di batteriologia, virologia, ed immunologia ed annali dell'Ospedale Maria Vittoria di Torino 1970;63(7):235-8.
1970: Dianzani F; Gagnoni S; Buckler C E; Baron S
Studies of the induction of interferon system by nonreplicating Newcastle disease virus.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1970;133(1):324-8.
1969: Billiau A; Buckler C E; Dianzani F; Uhlendorf C; Baron S
Induction of the interferon mechanism by single-stranded RNA: potentiation by polybasic substances.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1969;132(2):790-6.
1969: Grasso A; Gagnoni G; Cantagalli P; Dianzani F; Piazzi S E
[Hemagglutinin of rubella virus: its characteristics and uses in epidemiology and clinical medicine]
Giornale di malattie infettive e parassitarie 1969;21(7):603-15.
1969: Gagnoni G; Cantagalli P; Grasso A; Dianzani F
Effect of reagents affecting specific groups of proteins on the haemagglutinating activity of rubella virus.
Acta virologica 1969;13(3):235-8.
1969: Dianzani F; Buckler C E; Baron S
Effect of cycloheximide on the antiviral action of interferon.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1969;130(2):519-23.
1969: Dianzani F; Rita G; Cantagalli P; Gagnoni S
Effect of DEAE-dextran on interferon production and protective effect in mice treated with the double-stranded polynucleotide complex polyinosinic-polycytidylic acid.
Journal of immunology (Baltimore, Md. : 1950) 1969;102(1):24-7.
1968: Dianzani F; Buckler C E; Baron S
Kinetics of the development of factors responsible for inerferon-induced resistance.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1968;129(2):535-8.
1968: Grasso A; Vierucci A; Messina G; Dianzani F
[Finding of hemagglutination-inhibiting antibodies against German measles virus in normal subjects of different age groups]
Nuovi annali d'igiene e microbiologia 1968;19(5):354-60.
1968: Grasso A; Rubbiani U; Dianzani F
[Data on hemagglutination-inhibiting antibodies against rubella virus in paired samples of maternal-fetal blood]
Nuovi annali d'igiene e microbiologia 1968;19(4):250-4.
1968: Dianzani F; Cantagalli P; Gagnoni S; Rita G
Effect of DEAE-dextran on production of interferon induced by synthetic double-stranded RNA in L cell cultures.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1968;128(3):708-10.
1968: Dianzani F; Quercioli A; Quercioli L D; Gagnoni S
Influence of DEAE-dextran on plaque production by Semliki forest virus.
Acta virologica 1968;12(3):275-6.
1968: Guerra R; Frezzotti R; Bonanni R; Rita G; Dianzani F
[Possibilities of treatment of human herpetic keratitis with an inducer of the interferon system]
Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica 1968;17(2):1513-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Ferdinando Dianzani

Research Profile (preview)

Chemicals & Drugs

Phenomena

Concepts & Ideas

Anatomy

Living Beings

Disorders

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Ferdinando Dianzani (preview)

All Publications